KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $176.2 million.

  • Staar Surgical's Cash & Equivalents rose 740.96% to $176.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $176.2 million, marking a year-over-year increase of 740.96%. This contributed to the annual value of $144.2 million for FY2024, which is 2124.09% down from last year.
  • Latest data reveals that Staar Surgical reported Cash & Equivalents of $176.2 million as of Q3 2025, which was up 740.96% from $167.1 million recorded in Q2 2025.
  • Staar Surgical's 5-year Cash & Equivalents high stood at $224.0 million for Q1 2024, and its period low was $86.5 million during Q4 2022.
  • In the last 5 years, Staar Surgical's Cash & Equivalents had a median value of $170.1 million in 2021 and averaged $161.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 5669.63% in 2022, then surged by 14900.41% in 2024.
  • Staar Surgical's Cash & Equivalents (Quarter) stood at $199.7 million in 2021, then plummeted by 56.7% to $86.5 million in 2022, then surged by 111.65% to $183.0 million in 2023, then dropped by 21.24% to $144.2 million in 2024, then grew by 22.19% to $176.2 million in 2025.
  • Its last three reported values are $176.2 million in Q3 2025, $167.1 million for Q2 2025, and $173.1 million during Q1 2025.